SEARCH
Enter your search term below:
INSIGHTS / News
University spin-out “Azellon” announces recruitment phase of knee repair clinical trial
Azellon Ltd, (“Azellon”), a spin-out from the University of Bristol and the developer of stem cell therapies for tissue repair, today announced that recruitment had commenced for the phase I/IIa trial of its Cell Bandage for knee meniscus repair.
Built upon the pioneering work of Professor Anthony Hollander from the University’s School of Cellular and Molecular Medicine, the Azellon procedure takes stem cells, harvested from the patient’s own bone marrow, grows them on a structural bio-scaffold, and two weeks later implants the newly created Cell Bandage into the patient’s knee.
Read the full story on the University website
Mailing List sign-up
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.
Close 
Mailing List sign-up
LATEST
TWEETS
And that’s a wrap! What an incredible morning at #2020Invest. Thank you to all 244 of you who attended the event &… twitter.com/i/web/status/13341…
️If you would like to get in contact with, or find out more about, any of the companies who pitched today at… twitter.com/i/web/status/13341…Pitch 18: @AquarkT “We have created the basis for the new generation of quantum technology devices for sensing & me… twitter.com/i/web/status/13340…
Pitch 17 @intelligentAIuk: “Our intelligent AI risk management platform helps insurers drive risk mitigation & save… twitter.com/i/web/status/13340…
